Paul H. Johnson

2.7k total citations
43 papers, 2.1k citations indexed

About

Paul H. Johnson is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Paul H. Johnson has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Oncology. Recurrent topics in Paul H. Johnson's work include Cell Adhesion Molecules Research (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Paul H. Johnson is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). Paul H. Johnson collaborates with scholars based in United States, Canada and United Kingdom. Paul H. Johnson's co-authors include Lawrence I. Grossman, Steven C. Quay, Henry R. Costantino, Gordon Brandt, Lisbeth Illum, M. Laskowski, Brian F.P. Edwards, Robert L. Sinsheimer, Mary Prieve and Deborah A. Zajchowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Paul H. Johnson

40 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul H. Johnson United States 23 1.1k 375 289 248 139 43 2.1k
Eric Ka‐Wai Hui United States 34 1.1k 0.9× 103 0.3× 235 0.8× 160 0.6× 101 0.7× 66 2.5k
Andrew J. S. Jones United States 26 1.7k 1.5× 506 1.3× 87 0.3× 177 0.7× 201 1.4× 67 2.8k
Jamal Temsamani France 30 3.2k 2.8× 164 0.4× 545 1.9× 309 1.2× 198 1.4× 66 4.3k
Robert M. Lafrenie Canada 31 1.1k 1.0× 78 0.2× 462 1.6× 134 0.5× 213 1.5× 68 2.8k
Pascal Bailon United States 20 1.1k 0.9× 73 0.2× 321 1.1× 114 0.5× 162 1.2× 43 2.8k
Kazuaki Kajimoto Japan 27 1.1k 1.0× 229 0.6× 83 0.3× 143 0.6× 242 1.7× 80 2.0k
Werner Schröder Germany 23 1.0k 0.9× 68 0.2× 90 0.3× 93 0.4× 79 0.6× 48 1.8k
Caiyun Fu China 19 2.2k 1.9× 123 0.3× 442 1.5× 113 0.5× 295 2.1× 62 3.5k
Ann L. Hubbard United States 33 2.3k 2.1× 48 0.1× 564 2.0× 230 0.9× 102 0.7× 49 4.2k
Gurpreet Singh India 19 1.4k 1.2× 65 0.2× 69 0.2× 177 0.7× 160 1.2× 73 2.3k

Countries citing papers authored by Paul H. Johnson

Since Specialization
Citations

This map shows the geographic impact of Paul H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. Johnson more than expected).

Fields of papers citing papers by Paul H. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. Johnson. The network helps show where Paul H. Johnson may publish in the future.

Co-authorship network of co-authors of Paul H. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H. Johnson. A scholar is included among the top collaborators of Paul H. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H. Johnson. Paul H. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Paul H., Diane E. Frank, & Henry R. Costantino. (2008). Discovery of tight junction modulators: significance for drug development and delivery. Drug Discovery Today. 13(5-6). 261–267. 28 indexed citations
2.
Costantino, Henry R., Alexis Leonard, Gordon Brandt, Paul H. Johnson, & Steven C. Quay. (2008). Intranasal administration of acetylcholinesterase inhibitors. BMC Neuroscience. 9(S3). S6–S6. 28 indexed citations
3.
Fuller, Mark E., et al.. (2007). The Trp Cage Motif as a Scaffold for the Display of a Randomized Peptide Library on Bacteriophage T7. Journal of Biological Chemistry. 282(13). 9813–9824. 23 indexed citations
4.
5.
Costantino, Henry R., Lisbeth Illum, Gordon Brandt, Paul H. Johnson, & Steven C. Quay. (2007). Intranasal delivery: Physicochemical and therapeutic aspects. International Journal of Pharmaceutics. 337(1-2). 1–24. 459 indexed citations
6.
Mashhoon, Neda, Cynthia M. Pruss, Michael Carroll, Paul H. Johnson, & Norbert O. Reich. (2006). Selective Inhibitors of Bacterial DNA Adenine Methyltransferases. SLAS DISCOVERY. 11(5). 497–510. 52 indexed citations
7.
Leonard, Alexis, Daniel L. Morris, Anthony Sileno, et al.. (2006). Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. Journal of Pharmaceutical Sciences. 95(6). 1364–1371. 38 indexed citations
8.
Johnson, Paul H. & Steven C. Quay. (2005). Advances in nasal drug delivery through tight junction technology. Expert Opinion on Drug Delivery. 2(2). 281–298. 54 indexed citations
9.
Kuhn, Irene, Marty F. Bartholdi, Hugh Salamon, et al.. (2001). Identification of AKT-regulated genes in inducible MERAkt cells. Physiological Genomics. 7(2). 105–114. 18 indexed citations
10.
Malkowski, Michael G., et al.. (1997). The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence 1 aEdited by I. A. Wilson. Journal of Molecular Biology. 266(2). 367–380. 22 indexed citations
11.
Vitali, Jacqueline, Philip D. Martin, Michael G. Malkowski, et al.. (1996). Structure of a Bovine Thrombin–Hirudin51−65Complex Determined by a Combination of Molecular Replacement and Graphics. Incorporation of Known Structural Information in Molecular Replacement. Acta Crystallographica Section D Biological Crystallography. 52(3). 453–464. 6 indexed citations
12.
Malkowski, Michael G., et al.. (1995). The Crystal Structure of Recombinant Human Neutrophil-activating Peptide-2 (M6L) at 1.9-Å Resolution. Journal of Biological Chemistry. 270(13). 7077–7087. 68 indexed citations
13.
14.
Winant, Richard C., et al.. (1991). Chemical modifications and amino acid substitutions in recombinant hirudin that increase hirudin-thrombin affinity. Biochemistry. 30(5). 1271–1277. 15 indexed citations
15.
Johnson, Paul H., Ping Sze, Richard C. Winant, et al.. (1991). Structure-Function and Refolding Studies of the Thrombin-Specific Inhibitor Hirudin. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 41–48. 5 indexed citations
16.
Pizzo, Salvatore V., Richard Friedberg, Ping Sze, et al.. (1990). Recombinant hirudin displaces human factor Xa from its endothelial binding sites. Thrombosis Research. 57(5). 803–806. 3 indexed citations
17.
Castor, C. William, Daniel A. Walz, Paul H. Johnson, et al.. (1990). Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.. PubMed. 116(4). 516–26. 20 indexed citations
18.
Green, Christopher J., Robert Charles, Brian F.P. Edwards, & Paul H. Johnson. (1989). Identification and Characterization of PF4varl, a Human Gene Variant of Platelet Factor 4. Molecular and Cellular Biology. 9(4). 1445–1451. 10 indexed citations
19.
20.
Tatti, Kathleen M., Michael E. S. Hudspeth, Paul H. Johnson, & Lawrence I. Grossman. (1978). Enhancement of buoyant separations between DNAs in preparative CsCl gradients containing distamycin A or netropsin. Analytical Biochemistry. 89(2). 561–571. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Ka‐Wai Hui Breakdown of academic impact, for papers by Andrew J. S. Jones Breakdown of academic impact, for papers by Jamal Temsamani Breakdown of academic impact, for papers by Robert M. Lafrenie Breakdown of academic impact, for papers by Pascal Bailon Breakdown of academic impact, for papers by Kazuaki Kajimoto Breakdown of academic impact, for papers by Werner Schröder Breakdown of academic impact, for papers by Caiyun Fu Breakdown of academic impact, for papers by Ann L. Hubbard Breakdown of academic impact, for papers by Gurpreet Singh
Rankless by CCL
2026